Elevai Labs (ELAB) Competitors $0.02 0.00 (-15.65%) (As of 11/15/2024 08:54 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ELAB vs. MAAQ, SRNE, SONN, GLMD, SLRX, PHIO, OGEN, DRMA, SXTC, and BONShould you be buying Elevai Labs stock or one of its competitors? The main competitors of Elevai Labs include Mana Capital Acquisition (MAAQ), Sorrento Therapeutics (SRNE), Sonnet BioTherapeutics (SONN), Galmed Pharmaceuticals (GLMD), Salarius Pharmaceuticals (SLRX), Phio Pharmaceuticals (PHIO), Oragenics (OGEN), Dermata Therapeutics (DRMA), China SXT Pharmaceuticals (SXTC), and Bon Natural Life (BON). These companies are all part of the "pharmaceutical products" industry. Elevai Labs vs. Mana Capital Acquisition Sorrento Therapeutics Sonnet BioTherapeutics Galmed Pharmaceuticals Salarius Pharmaceuticals Phio Pharmaceuticals Oragenics Dermata Therapeutics China SXT Pharmaceuticals Bon Natural Life Elevai Labs (NASDAQ:ELAB) and Mana Capital Acquisition (NASDAQ:MAAQ) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership. Is ELAB or MAAQ more profitable? Mana Capital Acquisition has a net margin of 0.00% compared to Elevai Labs' net margin of -223.41%. Mana Capital Acquisition's return on equity of 0.00% beat Elevai Labs' return on equity.Company Net Margins Return on Equity Return on Assets Elevai Labs-223.41% -183.22% -113.15% Mana Capital Acquisition N/A N/A N/A Does the MarketBeat Community believe in ELAB or MAAQ? Mana Capital Acquisition received 1 more outperform votes than Elevai Labs when rated by MarketBeat users. CompanyUnderperformOutperformElevai LabsN/AN/AMana Capital AcquisitionOutperform Votes1100.00% Underperform VotesNo Votes Which has higher valuation and earnings, ELAB or MAAQ? Mana Capital Acquisition has lower revenue, but higher earnings than Elevai Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevai Labs$1.71M0.27-$4.30M-$0.31-0.07Mana Capital AcquisitionN/AN/AN/AN/AN/A Does the media prefer ELAB or MAAQ? In the previous week, Elevai Labs had 4 more articles in the media than Mana Capital Acquisition. MarketBeat recorded 4 mentions for Elevai Labs and 0 mentions for Mana Capital Acquisition. Elevai Labs' average media sentiment score of 0.18 beat Mana Capital Acquisition's score of 0.00 indicating that Elevai Labs is being referred to more favorably in the media. Company Overall Sentiment Elevai Labs Neutral Mana Capital Acquisition Neutral Do institutionals and insiders believe in ELAB or MAAQ? 22.2% of Elevai Labs shares are held by institutional investors. Comparatively, 68.4% of Mana Capital Acquisition shares are held by institutional investors. 37.0% of Elevai Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryMana Capital Acquisition beats Elevai Labs on 5 of the 9 factors compared between the two stocks. Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAB vs. The Competition Export to ExcelMetricElevai LabsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$460,000.00$6.31B$4.79B$8.63BDividend YieldN/A8.11%7.42%4.07%P/E Ratio-0.079.70118.6717.38Price / Sales0.27362.621,352.5385.50Price / CashN/A50.7536.8135.17Price / Book0.109.696.276.04Net Income-$4.30M$149.16M$112.82M$223.02M7 Day PerformanceN/A-5.13%111.94%-0.13%1 Month PerformanceN/A-4.61%116.44%4.96%1 Year PerformanceN/A29.47%155.06%25.34% Elevai Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELABElevai Labs0.7755 of 5 stars$0.02-15.6%N/AN/A$460,000.00$1.71M-0.0718Gap DownHigh Trading VolumeMAAQMana Capital AcquisitionN/A$0.27-13.1%N/A-74.5%$2.16MN/A0.001Gap UpHigh Trading VolumeSRNESorrento TherapeuticsN/A$0.00flatN/A-93.3%$2.10M$62.84M0.00800Analyst ForecastGap DownSONNSonnet BioTherapeutics1.8812 of 5 stars$3.00-2.6%N/A+109.7%$2.05M$55,881.000.0012GLMDGalmed Pharmaceuticals1.1879 of 5 stars$3.10+3.7%N/A-40.0%$2.00MN/A-0.1820Gap DownSLRXSalarius Pharmaceuticals0.4151 of 5 stars$1.38-2.1%N/A-75.7%$1.99M$1.84M-0.1120PHIOPhio Pharmaceuticals2.2202 of 5 stars$2.23-5.1%N/A-75.9%$1.92MN/A-0.118Gap UpOGENOragenicsN/A$0.32-5.9%N/AN/A$1.90M$40,000.00-0.045DRMADermata Therapeutics2.2155 of 5 stars$1.19-3.3%N/A-89.3%$1.80MN/A-0.058SXTCChina SXT Pharmaceuticals1.1878 of 5 stars$0.43-6.5%N/A-79.8%$1.75M$1.93M0.0090Positive NewsGap DownBONBon Natural LifeN/A$1.38-4.2%N/A-67.0%$1.62M$29.52M0.00100Gap Down Related Companies and Tools Related Companies MAAQ Alternatives SRNE Alternatives SONN Alternatives GLMD Alternatives SLRX Alternatives PHIO Alternatives OGEN Alternatives DRMA Alternatives SXTC Alternatives BON Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ELAB) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevai Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevai Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
